Preclinical results with I(f) current inhibition by ivabradine

Area of Science:

• Cardiology
• Pharmacology
• Physiology

Background:

• The sinoatrial node regulates heart rate via the I(f) current.
• Chronic heart diseases involve complex cardiac and vascular remodeling processes.
• Understanding novel therapeutic mechanisms for heart rate modulation is crucial.

Purpose of the Study:

• To investigate the effects of ivabradine, a selective I(f) current inhibitor, on cardiac function and hemodynamics.
• To evaluate the impact of ivabradine on myocardial ischemia and cardiac remodeling.
• To explore the potential of ivabradine in preventing vascular dysfunction in preclinical models.

Main Methods:

• Administered ivabradine to assess its effects on heart rate, atrioventricular conduction, and left ventricular function.
• Evaluated myocardial oxygen consumption and ischemic regions.
• Utilized animal models of chronic heart failure and dyslipidemia to assess long-term effects on cardiac structure and vascular health.

Main Results:

• Ivabradine caused dose-dependent heart rate reduction without adverse effects on cardiac contractility or vascular tissues.
• Improved stroke volume and preserved cardiac output at rest and during exercise.
• Reduced ischemia severity, improved cardiac hemodynamics, and attenuated adverse cardiac remodeling in heart failure models.
• Prevented endothelial dysfunction in renal and cerebrovascular tissues in dyslipidemic mice.

Conclusions:

• Ivabradine's selective heart rate reduction offers therapeutic potential beyond symptom management.
• Long-term ivabradine administration may influence multiple mechanisms involved in cardiac and vascular remodeling.
• Preclinical data support further investigation into ivabradine's role in managing chronic heart and vascular diseases.